Once a POU receives a thermal shipper with our vaccine, they have three options for storage: The intent is to utilize Pfizer-strategic transportation partners to ship by air to major hubs within a country/region and by ground transport to dosing locations. Our distribution is built on a flexible just-in-time system which will ship the frozen vials to the point of vaccination. We have developed detailed logistical plans and tools to support effective vaccine transport, storage and continuous temperature monitoring. We have also developed packaging and storage innovations to be fit for purpose to meet the needs of our global network. Our track record gives us confidence in our ability to quickly scale and manufacture and distribute large quantities of a high-quality COVID-19 vaccine, leveraging multiple sites in the US and Europe. We have years of proven experience in supply chain and cold chain management, and we are accelerating the development of innovative technologies to further advance our capabilities as a supply chain leader. We have experience working with customers in all markets to ensure success. Today, Pfizer manufactures more than 200 million doses of Pfizer vaccines annually and is one of the largest sterile injectables suppliers in the world, producing more than 1 billion sterile units per year.
Pfizer is a proven, reliable multinational vaccine producer, supplying vaccines to more than 165 countries. How will Pfizer maintain vaccine integrity during distribution?.The combination of OWS logistics expertise coupled with Pfizer’s deep manufacturing and distribution expertise provides a solid foundation for success. a second dose inventory management system.synchronization of our vaccine shipments with the delivery of an ancillary kit that contains supplies required to administer the vaccine, and.a direct ship distribution strategy that minimizes the transportation time from our facility to the point of use,.General Gustave Perna and the Operation Warp Speed team have offered any and all support and we are grateful for that as what we are tasked with is no simple feat.Ī few areas where we have been collaborating include: government on several fronts as we strategize and plan for our future COVID-19 vaccine distribution effort, keeping in mind that our vaccine candidate needs to clear a number of efficacy, safety and manufacturing hurdles before we submit for any FDA consideration. Pfizer is working very closely with the U.S. Research and Business Development Partnerships.Unleashing the next wave of scientific innovations
0 kommentar(er)
